Javier de la Rubia

Javier de la Rubia

UNVERIFIED PROFILE

Are you Javier de la Rubia?   Register this Author

Register author
Javier de la Rubia

Javier de la Rubia

Publications by authors named "Javier de la Rubia"

Are you Javier de la Rubia?   Register this Author

100Publications

4087Reads

19Profile Views

Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma.

Ann Hematol 2019 Aug 16;98(8):2013-2015. Epub 2019 Mar 16.

Hematology Service, University Hospital Doctor Peset, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03663-5DOI Listing
August 2019

Therapeutic plasma exchange: Review of current indications.

Transfus Apher Sci 2019 Jun 18;58(3):247-253. Epub 2019 Apr 18.

Hematology Service, University Hospital Doctor Peset, Valencia, Spain; Internal Medicine, School of Medicine and Dentistry, Catholic University of Valencia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2019.04.007DOI Listing
June 2019

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.

N Engl J Med 2019 01 9;380(4):335-346. Epub 2019 Jan 9.

From the Department of Haematology, University College London Hospitals, Cardiometabolic Program, National Institute for Health Research UCLH-UCL Biomedical Research Center, London (M.S.); the Division of Hematology, Department of Internal Medicine, Ohio State University, Columbus (S.R.C.); Fondazione Istituti di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, and the Department of Pathophysiology and Transplantation, University of Milan, Milan (F.P.); the Department of Hematology, Saint-Antoine University Hospital, Paris (P.C.); the Department of Medicine 1, Division of Hematology and Hemostasis, Medical University of Vienna, Vienna (P.K.); the Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland (J.A.K.H.); the Division of Hematology, Duke University School of Medicine, Durham, NC (A.M.); the Hematology Department, Universidad Católica de Valencia Hospital Dr. Peset, Valencia, Spain (J.R.); the Departments of Medicine and Laboratory Medicine, St. Michael's Hospital and University of Toronto, Toronto (K.P.); and Clinical Development, Ablynx, Zwijnaarde, Belgium (F.C., D.B., H.D.W., R.K.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1806311DOI Listing
January 2019

Practice guidelines for the emergency treatment of thrombotic microangiopathy.

Med Clin (Barc) 2018 08 11;151(3):123.e1-123.e9. Epub 2018 Mar 11.

Servicio de Hematología, Hospital Universitario y Politécnico La Fe, Valencia, España; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2018.01.013DOI Listing
August 2018

Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review.

Onco Targets Ther 2018 6;11:4583-4590. Epub 2018 Aug 6.

Hematology Service, University Hospital Doctor Peset, Valencia, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S141053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084082PMC
August 2018

Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option.

Nefrologia 2017 Sep - Oct;37(5):478-491

Servicio de Nefrología, Hospital Universitario Dr. Peset, Valencia, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nefro.2017.01.006DOI Listing
July 2018

Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial.

J Clin Oncol 2018 07 2;36(20):2035-2043. Epub 2018 Feb 2.

Meletios Dimopoulos, National and Kapodistrian University of Athens, Athens, Greece; Katja Weisel, University Hospital of Tuebingen, Tuebingen, Germany; Niels W.C.J. van de Donk, VU Universiteit Medical Center, Amsterdam; Pieter Sonneveld, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Karthik Ramasamy, Oxford University Hospital and NIHR BRC Blood Theme, Oxford; Matthew Streetly, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Barbara Gamberi, Arcispedale S. Maria Nuova, Reggio Emilia; Massimo Offidani, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona; Antonio Ardizzoia, Oncology Department, ASST Lecco, Lecco, Italy; Frank Bridoux, University Hospital and University of Poitiers, Poitiers, France; Javier de la Rubia, Hematology Service University Hospital Doctor Peset and Universidad Católica de Valencia "San Vicente Mártir," Valencia; Maria-Victoria Mateos, Instituto de Investigación Biomédica de Salamanca and University of Salamanca, Salamanca, Spain; Elisabeth Kueenburg, Shona Collins, Antonia Di Micco, Barbara Rosettani, and Pamela Bacon, Celgene International, Boudry, Switzerland; and Yan Li, Translational Development and Clinical Pharmacology, Celgene Corporation, Summit, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.1742DOI Listing
July 2018

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials.

J Clin Oncol 2017 Sep 12;35(25):2900-2910. Epub 2017 May 12.

Juan-Jose Lahuerta, Maria-Teresa Cedena, Joaquin Martinez-Lopez, and María-Luisa Martín-Ramos, Hospital 12 de Octubre, CIBERONC; Raquel de Paz, Hospital Universitario La Paz; Rafael Martinez, Hospital Clínico San Carlos; Adrian Alegre, Hospital Universitario La Princesa, Madrid; Bruno Paiva and Jesus F. San-Miguel, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona; Laura Rosiñol, and Joan Blade, Hospital Clínic de Barcelona, Barcelona; Maria-Belen Vidriales, Noemi Puig, Norma C. Gutierrez, Alejandro Martin, and María-Victoria Mateos, Hospital Universitario de Salamanca Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBERONC; Alberto Orfao, Servicio General de Citometría-NUCLEOS, Centro de Investigación del Cancer (IBMCC-USAL, CSIC), IBSAL and Department of Medicine, Universidad de Salamanca, CIBERONC, Salamanca; Lourdes Cordón and Javier De la Rubia, Hospital Universitario y Politécnico La Fe; Ana-Isabel Teruel, Hospital Clínico de Valencia, Valencia; Albert Oriol, Hospital Germans Trias i Pujol, Badalona; María-Asunción Echeveste, Hospital de Donostia, San Sebastian; Felipe de Arriba, Hospital Morales Meseguer, Murcia; Miguel T. Hernandez, Hospital Universitario de Canarias, Tenerife; Luis Palomera, Hospital Universitario Lozano Blesa, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.2517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568033PMC
September 2017

The safety of daratumumab for the treatment of multiple myeloma.

Expert Opin Drug Saf 2017 Jun 22;16(6):753-760. Epub 2017 May 22.

a Hematology Service , University Hospital Doctor Peset , Valencia , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1328053DOI Listing
June 2017

Immunotherapy for the treatment of Hodgkin lymphoma.

Expert Rev Hematol 2017 05 12;10(5):417-423. Epub 2017 Apr 12.

a Hematology Service , University Hospital Doctor Peset , Valencia , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1313701DOI Listing
May 2017

Which therapies will move to the front line for multiple myeloma?

Expert Rev Hematol 2017 05 24;10(5):383-392. Epub 2017 Apr 24.

a Hematology Service , University Hospital Doctor Peset , Valencia , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1317589DOI Listing
May 2017

Synchronization of fluctuating delay-coupled chaotic networks.

Phys Rev E 2017 May 16;95(5-1):052210. Epub 2017 May 16.

Departamento de Física Fundamental, UNED 28040, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevE.95.052210DOI Listing
May 2017

Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma.

Future Oncol 2015 10;11(11):1643-58. Epub 2015 Apr 10.

1Hematology Service, University Hospital Doctor Peset, Avda Gaspar Aguilar 90, 46017 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.51DOI Listing
February 2016

Infectious complications in patients with newly diagnosed multiple myeloma: A complication from the past?

Leuk Lymphoma 2016 Feb 16;57(2):258-268. Epub 2015 Nov 16.

a Hematology Service , University Hospital Dr. Peset , Valencia , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1088647DOI Listing
February 2016

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Biol Blood Marrow Transplant 2015 Dec 30;21(12):2039-2051. Epub 2015 Sep 30.

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757494PMC
December 2015

Clinical treatment of newly diagnosed multiple myeloma.

Expert Rev Hematol 2015 Oct 1;8(5):595-611. Epub 2015 Sep 1.

a 1 Hematology Service, University Hospital Doctor Peset, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2015.1078236DOI Listing
October 2015

[Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group].

Med Clin (Barc) 2015 Apr 27;144(7):331.e1-331.e13. Epub 2014 Nov 27.

Servicio de Hemoterapia y Hemostasia, Hospital Clínic Universitari, Barcelona, España. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2014.09.013DOI Listing
April 2015

Spatial spread of the Hantavirus infection.

Phys Rev E Stat Nonlin Soft Matter Phys 2015 Mar 9;91(3):032703. Epub 2015 Mar 9.

Departamento de Física Fundamental, Universidad Nacional de Educación a Distancia-UNED, Paseo Senda del Rey 9, E-28040 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevE.91.032703DOI Listing
March 2015

Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective.

Eur J Haematol 2015 Jan 26;94(1):12-22. Epub 2014 May 26.

Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ejh.12362
Publisher Site
http://dx.doi.org/10.1111/ejh.12362DOI Listing
January 2015

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

Ann Hematol 2014 Aug 5;93(8):1421-2. Epub 2013 Dec 5.

Hematology Department, Hospital Universitari i Politècnic La Fe, Bulevard Sur s/n, Valencia, 46026, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-013-1970-3DOI Listing
August 2014

European perspective on multiple myeloma treatment strategies in 2014.

Oncologist 2014 Aug 25;19(8):829-44. Epub 2014 Jul 25.

Department of Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria; Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands; Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom; Department of Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, Barcelona, Spain; Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S. Giovanni Battista, Ospedale Molinette, Turin, Italy; Institute of Hematology and Medical Oncology, Seragnoli, Bologna, Italy; Haemato-Oncology Unit, Royal Marsden Hospital, Surrey, United Kingdom; Hematology Service, University Hospital La Fe, Valencia, Spain; Department of Hematology, University Hospital, Leuven, Belgium; Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece; Universitätsklinik Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany; Service d'Hématologie, Centre Hospitalier Universitaire, Lille, France; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; University Hospital, Nantes, France; Karolinska Institute, Stockholm, Sweden; Department of Hematology, Center Lillebaelt, University of Southern Denmark, Odense, Denmark; Clinica Universidad de Navarra, Centro Investigaciones Medicas Aplicada, Pamplona, Spain; Department of Hemato-oncology, University of Ostrava, Ostrava, Czech Republic; University of Giessen, Giessen, Germany.

View Article

Download full-text PDF

Source
http://szpiczak.org/lang/aktualnosci/publikacje/rok_2014/The
Web Search
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2014-0042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122482PMC
August 2014

Comment on "Outcomes of autologous transplantation for multiple myeloma according to different induction regimens".

Rev Bras Hematol Hemoter 2014 Mar;36(2):96-7

University Hospital La Fe, Valencia, Spain, University Hospital La Fe, Valencia, Spain ; Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain, Universidad Católica de Valencia "San Vicente Mártir", Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5581/1516-8484.20140020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005502PMC
March 2014

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.

N Engl J Med 2013 Aug;369(5):438-47

Hospital Universitario de Salamanca, Instituto de Biología Molecular y Celular del Cáncer, Universidad de Salamanca-Consejo Superior de Investigaciones Científicas, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1300439DOI Listing
August 2013

Stage-dependent model for Hantavirus infection: the effect of the initial infection-free period.

Phys Rev E Stat Nonlin Soft Matter Phys 2013 Apr 11;87(4):042706. Epub 2013 Apr 11.

Departamento de Física Fundamental, Universidad Nacional de Educación a Distancia, Paseo Senda del Rey 9, E-28040 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevE.87.042706DOI Listing
April 2013

Role of autologous bone marrow transplant in multiple myeloma.

Curr Opin Oncol 2012 Nov;24(6):733-41

Hematology Service, University Hospital La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328358f686DOI Listing
November 2012

Genomic analysis of high-risk smoldering multiple myeloma.

Haematologica 2012 Sep 13;97(9):1439-43. Epub 2012 Feb 13.

Servicio de Hematología del Hospital Universitario de Salamanca y Centro de Investigación del Cáncer-IBMCC (USAl-CIC), Universidad de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2011.060780DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436247PMC
September 2012

Bortezomib for previously untreated multiple myeloma.

Expert Rev Hematol 2011 Aug;4(4):381-98

Hematology Service, University Hospital La Fe. Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.11.38DOI Listing
August 2011

Impact of the conditioning regimen in patients with multiple myeloma who undergo autologous transplantation.

J Clin Oncol 2011 May 11;29(15):e449; author reply e450. Epub 2011 Apr 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.33.7832DOI Listing
May 2011

[Thrombotic thrombocytopenic purpura].

Med Clin (Barc) 2011 Apr 24;136(12):534-40. Epub 2010 Apr 24.

Servicio de Hematología, Hospital La Fe, Valencia, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2010.02.011DOI Listing
April 2011

Treatment of multiple myeloma in the elderly: realities and hopes.

Leuk Lymphoma 2011 Jan 15;52(1):9-14. Epub 2010 Nov 15.

University Hospital La Fe, Universidad Catolica de Valencia San Vicente Martir, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2010.530361DOI Listing
January 2011

DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?

Leuk Lymphoma 2010 Nov;51(11):1960-1

Hematology Service, Hospital La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2010.527410DOI Listing
November 2010

Patterns of spiral wave attenuation by low-frequency periodic planar fronts.

Chaos 2007 Mar;17(1):015109

Departamento de Física Fundamental, UNED, 28040 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1063/1.2404640DOI Listing
March 2007

Incidence of Wra antigen and anti-Wra in a Spanish population.

Transfusion 2005 Aug;45(8):1324-6

Department of Hematology, University Hospital La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2005.00196.xDOI Listing
August 2005

Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.

Blood Coagul Fibrinolysis 2005 Jun;16(4):297-9

Department of Haematology, Hospital Universitario La Fe, Av. Campanar 21, 46009 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mbc.0000169224.23550.3fDOI Listing
June 2005

Pegfilgrastim as adjunct to chemotherapy to mobilize hematopoietic stem cells.

Haematologica 2005 Feb;90(2):150

Servicio de Hematologia, La Fe University Hospital.

View Article

Download full-text PDF

Source
February 2005